🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this expanded access study is to learn about the long-term effe...
Status
Available
Location
Cortica Glendale
Start Date
TBD
Trial ID
NCT07093541
Treatments Being Tested
Ecopipam hydrochloride (HCl) is an investigational drug being studied for s...
Status
Completed
Location
SNBL Clinical Pharmacology Center, Inc.
Start Date
2011-08
Trial ID
NCT01408394
Treatments Being Tested
This is a single center, open-label, fixed sequence, drug-drug interaction ...
Status
Completed
Location
Syneos Health Clinical Research Services, LLC.
Start Date
2021-05-13
Trial ID
NCT04902105
Treatments Being Tested
THOROUGH QT/QTc STUDY TO EVALUATE THE EFFECTS OF ECOPIPAM (EBS-101) ON CARD...
Status
Completed
Location
PPD Austin Phase 1 Clinical Research Unit
Start Date
2023-03-15
Trial ID
NCT05841160
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
UC Riverside
Start Date
2020-10-02
Trial ID
NCT04492956
This study was an international, multicenter, open-label, long term extensi...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-10-04
Trial ID
NCT04114539
Treatments Being Tested
Standard food-effect study to identify the effect of food on ecopipam pharm...
Status
Completed
Location
ICON Early Phase Services
Start Date
2024-11-05
Trial ID
NCT06669091
Treatments Being Tested
This Phase 3 multicenter study evaluates the maintenance of efficacy, safet...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2023-01-31
Trial ID
NCT05615220
Treatments Being Tested
This study evaluates the effect of ecopipam tablets in children and adolesc...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-06-28
Trial ID
NCT04007991
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108